76 results match your criteria: "Kobe Proton Center[Affiliation]"

Prompt gammas imaging (PGI) is a promising method for observing a beam's shape and estimating the range of the beam from outside a subject. However 2-dimensional images of prompt gammas (PGs) during irradiation of protons were still difficult to measure. To achieve PGI, we developed a new gamma camera and imaged PGs while irradiating a phantom by proton beams.

View Article and Find Full Text PDF

Space-making particle therapy, which consists of surgical placement of a spacer followed by particle therapy, has become a solution to the problem of normal organs being exposed to a high radiation dose. A bioabsorbable spacer is particularly suitable for this purpose, but is not widely used. Surgical placement of a spacer is performed mostly to protect the digestive tract, but can also be used to protect the kidneys.

View Article and Find Full Text PDF

Definitive particle therapy using protons or carbon ions for dedifferentiated liposarcoma.

Clin Transl Radiat Oncol

November 2024

Department of Radiation Oncology, Hyogo Ion Beam Medical Center Kobe Proton Center, 1-6-8 Minatojima-Minamimachi, Chuo-ku, Kobe City, Hyogo, Japan.

Background: Particle therapy is effective for the treatment of soft tissue sarcomas. However, the clinical outcomes of definitive particle therapy, particularly for dedifferentiated liposarcoma (DDLS), remain unknown.

Purpose: To analyze the treatment outcomes of proton and carbon ion particle therapies for DDLS.

View Article and Find Full Text PDF

Comparison of clinical outcome between surgical treatment and particle beam therapy for pelvic bone sarcomas: A retrospective multicenter study in Japan.

J Orthop Sci

July 2024

Department of Orthopaedic Surgery, Graduate School of Medicine, Kobe University, Kobe 650-0017, Japan; Department of Rehabilitation Science, Graduate School of Health Sciences, Kobe University, Kobe 654-0142, Japan.

Article Synopsis
  • A multicenter study in Japan compared clinical outcomes for patients with pelvic bone sarcomas treated with surgery versus particle beam therapy (carbon-ion and proton).
  • The study included 116 patients, with 57 receiving surgery and 59 undergoing particle beam therapy, revealing differences in median age at diagnosis and tumor size between the groups.
  • Overall survival, local control, and metastasis-free survival rates were similar between the groups, but in chordoma patients, the particle beam therapy showed significantly better local control rates compared to surgery.
View Article and Find Full Text PDF
Article Synopsis
  • Real-time monitoring of radiation therapy beams aimed at patients is challenging due to a lack of external observation methods.
  • Researchers discovered that polyester fabrics can serve as effective scintillating materials to visualize radiation beams, producing light outputs comparable to traditional plastic scintillators.
  • By using CMOS cameras, clear images of proton beam spots on polyester cloths were captured, paving the way for improved surface beam imaging in radiation therapy.
View Article and Find Full Text PDF
Article Synopsis
  • This clinical trial aimed to assess the safety and effectiveness of a time-intensified treatment strategy for high-risk neuroblastoma, involving delayed local surgery following aggressive chemotherapy.
  • Seventy-five patients were enrolled, with a 3-year progression-free survival rate of 44.4% and an overall survival rate of 80.7%, indicating a significant response to therapy without any deaths during treatment.
  • However, there were high rates of adverse effects, with 48% experiencing severe complications and 25% facing major surgical issues, suggesting more research is needed to confirm findings and improve safety.
View Article and Find Full Text PDF

Methyl-C-L-methionine positron emission tomography for radiotherapy planning for recurrent malignant glioma.

Ann Nucl Med

April 2024

Department of Radiation Oncology and Proton Medical Research Center, Faculty of Medicine, University of Tsukuba, 2-1-1 Amakubo, Tsukuba, Ibaraki, 305-8576, Japan.

Objective: To investigate differences in uptake regions between methyl-C-L-methionine positron emission tomography (C-MET PET) and gadolinium (Gd)-enhanced magnetic resonance imaging (MRI), and their impact on dose distribution, including changing of the threshold for tumor boundaries.

Methods: Twenty consecutive patients with grade 3 or 4 glioma who had recurrence after postoperative radiotherapy (RT) between April 2016 and October 2017 were examined. The study was performed using simulation with the assumption that all patients received RT.

View Article and Find Full Text PDF

The Japanese nationwide cohort data of proton beam therapy for liver oligometastasis in breast cancer patients.

J Radiat Res

March 2024

Division of Proton Therapy, Radiation and Proton Therapy Center, Shizuoka Cancer Center Hospital, 1007 Shimonagakubo, Nagaizumi-cho, Suntou-gun, Shizuoka 411-8777, Japan.

A nationwide multicenter cohort study on particle therapy was launched by the Japanese Society for Radiation Oncology in Japan in May 2016. We analyzed the outcome of proton beam therapy (PBT) for liver oligometastasis in breast cancers. Cases in which PBT was performed at all Japanese proton therapy facilities between May 2016 and February 2019 were enrolled.

View Article and Find Full Text PDF

Clinical impact of spacer placement surgery with expanded polytetrafluoroethylene sheet for particle therapy.

Radiat Oncol

October 2023

Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Hyogo, Japan.

Background: Spacer placement surgery is useful in particle therapy (PT) for patients with abdominopelvic malignant tumors located adjacent to the gastrointestinal tract. This study aimed to assess the safety, efficacy, and long-term outcomes of spacer placement surgery using an expanded polytetrafluoroethylene (ePTFE) spacer.

Methods: This study included 131 patients who underwent ePTFE spacer placement surgery and subsequent PT between September 2006 and June 2019.

View Article and Find Full Text PDF

Purpose: To investigate the dose stability of craniospinal irradiation based on irradiation method of proton beam therapy (PBT).

Methods And Materials: Twenty-four pediatric and young adult brain tumor patients (age: 1-24 years) were examined. Treatment method was passive-scattered PBT (PSPT) in 8 patients and intensity-modulated PBT (IMPT) in 16 patients.

View Article and Find Full Text PDF
Article Synopsis
  • Proton beam therapy (PBT) is a potential treatment option for hepatocellular carcinoma (HCC), and this study aimed to compare its effectiveness with radiofrequency ablation (RFA) in treatment-naïve cases.
  • The study involved 95 patients treated with PBT and 836 treated with RFA, focusing on their recurrence-free survival (RFS) and overall survival (OS) after matching similar patients.
  • Results showed that while PBT had higher RFS rates at 1, 3, and 5 years compared to RFA, overall survival rates were similar, and PBT had fewer significant adverse events.
View Article and Find Full Text PDF

Background: Particle therapy has favorable dose distribution and high curability. However, radiotherapy for malignant tumors adjacent to the gastrointestinal tract is contraindicated owing to its low tolerance. To overcome this, combination treatment with surgery to make a space between the tumor and adjacent gastrointestinal tract followed by particle therapy has been developed.

View Article and Find Full Text PDF

A nationwide multicenter cohort study on particle therapy was launched by the Japanese Society for Radiation Oncology in Japan in May 2016. We analyzed the outcome of proton beam therapy (PBT) for liver oligometastasis of esophagogastric cancers. Cases in which PBT was performed at all PBT facilities in Japan between May 2016 and February 2019 were enrolled.

View Article and Find Full Text PDF

Cancer of the adolescent and young adult (AYA) generation has received increasing attention in recent years, however, there were few reports on radiotherapy for this area. As for pediatric cancer, many cancer of the AYA generation were treated with radiation therapy as the multidisciplinary treatment. In this article, we will review reproductive complications, which are considered to be particularly important complications of radiation therapy for AYA generation, and describe investigation of radiation therapy for cancers of the AYA generations at the Hyogo Cancer Center and the Hyogo Ion Beam Medical Center Kobe Proton Center.

View Article and Find Full Text PDF
Article Synopsis
  • This study assessed the effectiveness of two different proton beam therapy methods—passive scattered PBT (PSPT) and intensity modulated PBT (IMPT)—in treating pediatric patients requiring craniospinal irradiation.
  • It involved 24 patients, with a follow-up of 17 to 44 months, and compared the doses received by critical organs in two groups: one using the whole vertebral body technique and the other using the vertebral body sparing (VBS) technique.
  • Results indicated that IMPT resulted in lower doses to sensitive areas like the lens and improved coverage of the planning target volume (PTV), while the VBS technique effectively reduced radiation exposure to surrounding organs.
View Article and Find Full Text PDF

Prompt x-ray imaging is a promising method for observing the beam shape from outside a subject. However, its distribution is different from dose distribution, and thus a comparison with the dose is required. Meanwhile, luminescence imaging of water is a possible method for imaging the dose distribution.

View Article and Find Full Text PDF

Purpose: To evaluate the applicability of microdosimetric kinetic model (MKM) to helium-ion therapy by forming a spread-out Bragg peak (SOBP) of a helium-ion beam using the MKM developed for carbon-ion radiotherapy and confirming the predictions in biological experiments.

Methods: Using a ridge filter, a 90-mm wide SOBP for a 210 MeV/u helium-ion beam was created in a broad beam delivery system. The ridge filter was designed such that a uniform biological response was achieved with a cell survival rate of 7% over the SOBP region.

View Article and Find Full Text PDF

Japanese national oncological experts convened to evaluate the efficacy and safety of particle beam therapy (PT) for pulmonary, liver and lymph node oligometastases (P-OM, L-OM and LN-OM, respectively) and to conduct a statistically comparative analysis of the local control (LC) rate and overall survival (OS) rate of PT versus those of X-ray stereotactic body radiotherapy (X-SBRT) and X-ray intensity-modulated radiotherapy (X-IMRT). They conducted [1] an analysis of the efficacy and safety of metastasis-directed therapy with PT for P-OM, L-OM and LN-OM using a Japanese nationwide multi-institutional cohort study data set; [2] a systematic review of X-ray high-precision radiotherapy (i.e.

View Article and Find Full Text PDF
Article Synopsis
  • * A review of medical records from 2004 to 2018 identified eight patients who underwent ten local surgeries at areas previously treated with CIRT, with reasons including skin toxicity, bone collapse, and tumor regrowth.
  • * While local surgery is deemed feasible for select patients post-CIRT, particularly those with bone-related issues, careful monitoring of infection risks and the prescribed irradiation dose at surgical sites is crucial.
View Article and Find Full Text PDF

This study aimed to evaluate the efficacy and safety of particle therapy (proton beam therapy and carbon-ion radiotherapy) for esophageal cancer by analyzing prospective nationwide registry data from particle therapy facilities throughout Japan. Patients diagnosed with esophageal cancer who received particle therapy between May 2016 and June 2018 were recruited from the registries of 12 particle therapy centers in Japan. Eventually, we enrolled 174 patients who met the inclusion criteria.

View Article and Find Full Text PDF

Soft tissue myoepithelial carcinoma (MEC) is an extremely rare mesenchymal tumor that has a poor prognosis unless complete surgical resection is achieved. The present study reported a case of a 38-year-old woman with a tumor in the left paraspinal region at L2 to L3 with vertebral destruction. MEC was diagnosed based on molecular pathological examination of a biopsy specimen.

View Article and Find Full Text PDF

Infantile fibrosarcoma (IFS) commonly harbors ETS variant transcription factor 6 ()-neurotrophic receptor tyrosine kinase 3 () fusion. However, the recent accessibility to clinical next-generation sequencing (NGS) has revealed negative spindle cell sarcomas resembling IFS morphologically, involving and . The present report describes a pediatric case of spindle cell sarcoma with resembling IFS morphologically.

View Article and Find Full Text PDF

Background And Purpose: To determine the optimal primary tumor dose for cervical cancer treatment using computed tomography (CT)-based image-guided brachytherapy (IGBT).

Materials And Methods: We retrospectively reviewed 171 patients with cervical cancer who underwent both external beam radiation therapy (EBRT) and IGBT between May 2015 and December 2019. Majority of EBRT plan included central shielding technique.

View Article and Find Full Text PDF

Primary undifferentiated pleomorphic sarcoma (UPS) of the bone is rare. However, the common sites are the knee and proximal femur and humerus, while spinal involvement is rare. We report a case of primary UPS of the 11th thoracic vertebra, where corpectomy would have been difficult and extensive, treated with carbon ion radiotherapy.

View Article and Find Full Text PDF
Article Synopsis
  • This study analyzed the clinical outcomes of 187 patients with pelvic and retroperitoneal bone and soft tissue sarcoma (BSTS) treated at specialized centers in Japan.
  • The 3-year overall survival (OS) rate was 71.7%, while local control (LC) and progression-free survival (PFS) rates were 79.1% and 48.6%, respectively, with osteosarcoma showing significantly worse outcomes.
  • Key poor prognostic factors identified included larger tumor size, soft tissue tumors, presence of distant metastasis, and age, impacting overall survival, local control, and progression-free survival.
View Article and Find Full Text PDF